SLFN11 and small cell lung carcinoma: Given the potential role of SLFN11 as a biomarker for several drug classes, we expanded our drug analyses of SCLC with high versus low SLFN11 expression levels to a larger screen of 526 oncology drugs in 63 SCLC cell lines [12].